Clinical Study of the Efficacy and Safety of Spinal Cord Stimulation in Patients With Limb Motor Dysfunction Following Stroke
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Gao Chen
- Telefonnummer: 0571-87784713
- E-mail: d.chengao@163.com
Studiesteder
-
-
Zhejiang
-
Hangzhou, Zhejiang, Kina, 310009
- Rekruttering
- The Second Affiliated Hospital, Zhejiang University School of Medicine
-
Kontakt:
- Gao Chen
- Telefonnummer: 0571-87784713
- E-mail: d.chengao@163.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Hemiparesis resulting from a single ischemic or hemorrhagic stroke, with a disease duration of ≥6 months.
- Aged between 20 and 80 years (inclusive).
- Received regular rehabilitation therapy after stroke but with poor recovery of limb motor function; Fugl-Meyer Assessment upper extremity score >7 and <45, and lower extremity score >5 and <30.
- Partially preserved sensory function.
Exclusion Criteria:
- Severe systemic diseases (e.g., neurological disorders other than stroke, cancer, severe circulatory or respiratory diseases, liver or kidney failure, etc.) or other conditions that may impair the subject's motor or cognitive function.
- Presence of spinal cord-related nerve compression that could cause severe functional impairment.
- Women who are pregnant or breastfeeding.
- Use of anticoagulant, antiplatelet, antispasmodic, or antiepileptic medications prior to enrollment or during the study period.
- Severe joint contracture that, in the clinical investigator's opinion, precludes participation in the study.
- Severe mental illness or intellectual disability that prevents cooperation with treatment or follow-up questionnaires, with a Mini-Mental State Examination (MMSE) score <24.
- Presence of other implanted medical devices.
- Severe claustrophobia.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: spinal cord stimulation group
|
This trial is a single-arm, self-controlled exploratory clinical study.
Participants will undergo surgical implantation of spinal cord stimulation electrodes and receive programming and optimization of spinal cord stimulation parameters.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Fugl-Meyer Assessment (FMA)
Tidsramme: One year
|
One year
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Active and passive range of motion (A/PROM)
Tidsramme: One year
|
One year
|
|
|
Surface electromyography (sEMG):Mean amplitude
Tidsramme: One year
|
Mean surface electromyography (sEMG) amplitude, measured in microvolts (µV), will be derived from recordings of lower-limb muscles, including the tibialis anterior, gastrocnemius, quadriceps femoris, and biceps femoris.
Recordings will be obtained during standardized lower-limb motor tasks or voluntary muscle contractions.
Measurements will be analyzed separately for each muscle and, where applicable, for each side.
This parameter will be used to assess changes in lower-limb muscle activation after spinal cord stimulation.
Higher values indicate greater muscle activation.
|
One year
|
|
Modified Ashworth Scale (MAS)
Tidsramme: One year
|
The Modified Ashworth Scale (MAS) will be used to assess muscle tone and spasticity in lower-limb muscle groups, including hip flexors, hip extensors, hip adductors, hip abductors, knee flexors, knee extensors, ankle plantar flexors, and ankle dorsiflexors.
MAS grades range from 0 to 4, with an additional intermediate grade of 1+.
For statistical analysis, MAS grades may be converted to a 0-5 ordinal score, where 0 indicates no increase in muscle tone and 5 indicates that the affected limb is rigid in flexion or extension.
Higher scores indicate greater muscle tone and more severe spasticity.
Scores will be assessed separately for each side and compared across baseline and follow-up assessments.
|
One year
|
|
TMS-MEP:Amplitude and Waveform morphology
Tidsramme: One year
|
Motor evoked potential (MEP) amplitude and waveform morphology will be assessed from transcranial magnetic stimulation-induced MEP recordings of lower-limb muscles, including the tibialis anterior, gastrocnemius, quadriceps femoris, and biceps femoris.
MEP amplitude will be measured as the peak-to-peak amplitude, measured in microvolts (µV) or millivolts (mV), according to the study protocol.
The presence, reproducibility, and morphology of the MEP waveform will also be evaluated.
Measurements will be analyzed separately for each muscle and, where applicable, for each side.
These parameters will be used to evaluate changes in corticospinal excitability and motor pathway function after spinal cord stimulation.
|
One year
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 2025-1186
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .